Page 137 - Read Online

Page 318 Yasin et al. J Transl Genet Genom 2020;4:307-19 I https://doi.org/10.20517/jtgg.2020.30

histone deacetylase activities. Mol Cell 1998;2:851-61.
29. Lamar KMJ, Carvill GL. Chromatin remodeling proteins in epilepsy: lessons from CHD2-associated epilepsy. Frontiers in Molecular
Neuroscience 2018;11:208.
30. Zahir FR, Brown CJ. Epigenetic impacts on neurodevelopment: pathophysiological mechanisms and genetic modes of action. Pediatr Res
2011;69:92R-100.
31. van Loo KMJ, Martens GJM. Genetic and environmental factors in complex neurodevelopmental disorders. Curr Genomics 2007;8:429-
44.
32. Chelly J, Khelfaoui M, Francis F, Chérif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet
2006;14:701-13.
33. Shashi V, McConkie-Rosell A, Rosell B, Schoch K, Vellore K, et al. The utility of the traditional medical genetics diagnostic evaluation in
the context of next-generation sequencing for undiagnosed genetic disorders. Genet Med 2014;16:176-82.
34. Tucker T, Zahir FR, Griffith M, Delaney A, Chai D, et al. Single exon-resolution targeted chromosomal microarray analysis of known and
candidate intellectual disability genes. Eur J Hum Genet 2014;22:792-800.
35. Zoghbi HY, Beaudet AL. Epigenetics and human disease. Cold Spring Harb Perspect Biol 2016;8:a019497.
36. Muñoz-Najar U, Sedivy JM. Epigenetic control of aging. Antioxid Redox Signal 2010;14:241-59.
37. Zahir FR, Langlois S, Gall K, Eydoux P, Marra MA, et al. A novel de novo 1.1 Mb duplication of 17q21.33 associated with cognitive
impairment and other anomalies. Am J Med Genet Part A 2009;149A:1257-62.
38. Kordi-Tamandani DM, Sahranavard R, Torkamanzehi A. Analysis of association between dopamine receptor genes’ methylation and their
expression profile with the risk of schizophrenia. Psychiatr Genet 2013;23:183-7.
39. Bastaki KN, Alwan S, Zahir FR. Maternal prenatal exposures in pregnancy and autism spectrum disorder: an insight into the epigenetics
of drugs and diet as key environmental influences. Adv Neurobiol 2020;24:143-62.
40. Buss C, Entringer S, Swanson JM, Wadhwa PD. The role of stress in brain development: the gestational environment’s long-term effects
on the brain. Cerebrum 2012;2012:4.
41. Kundakovic M, Jaric I. The epigenetic link between prenatal adverse environments and neurodevelopmental disorders. Genes (Basel)
2017;8:104.
42. Monk C, Spicer J, Champagne FA. Linking prenatal maternal adversity to developmental outcomes in infants: the role of epigenetic
pathways. Dev Psychopathol 2012;24:1361-76.
43. Kim DR, Bale TL, Epperson CN. Prenatal programming of mental illness: current understanding of relationship and mechanisms. Curr
Psychiatry Rep 2015;17:5.
44. Perera F, Herbstman J. Prenatal environmental exposures, epigenetics, and disease. Reprod Toxicol 2011;31:363-73.
45. Breton-Larrivée M, Elder E, McGraw S. DNA methylation, environmental exposures and early embryo development. Anim Reprod
2019;16:465-74.
46. Dulac C. Brain function and chromatin plasticity. Nature 2010;465:728-35.
47. Hsieh J, Gage FH. Chromatin remodeling in neural development and plasticity. Curr Opin Cell Biol 2005;17:664-71.
48. Shilatifard A. Chromatin modifications by methylation and ubiquitination: implications in the regulation of gene expression. Annu Rev
Biochem 2006;75:243-69.
49. Kleefstra T, Kramer JM, Neveling K, Willemsen MH, Koemans TS, et al. Disruption of an EHMT1-associated chromatin-modification
module causes intellectual disability. Am J Hum Genet 2012;91:73-82.
50. Vissers LELM, Van Ravenswaaij CMA, Admiraal R, Hurst JA, De Vries BBA, et al. Mutations in a new member of the chromodomain
gene family cause CHARGE syndrome. Nat Genet 2004;36:955-7.
51. Zahir F, Firth HV, Baross A, Delaney AD, Eydoux P, et al. Novel deletions of 14q11.2 associated with developmental delay, cognitive
impairment and similar minor anomalies in three children. J Med Genet 2007;44:556-61.
52. Yasin H, Gibson WT, Langlois S, Stowe RM, Tsang ES, et al. A distinct neurodevelopmental syndrome with intellectual disability, autism
spectrum disorder, characteristic facies, and macrocephaly is caused by defects in CHD8. J Hum Genet 2019;64:271-80.
53. Kleefstra T, Schenck A, Kramer JM, van Bokhoven H. The genetics of cognitive epigenetics. Neuropharmacology 2014;80:83-94.
54. Pilarowski GO, Vernon HJ, Applegate CD, Boukas L, Cho MT, et al. Missense variants in the chromatin remodeler CHD1 are associated
with neurodevelopmental disability. J Med Genet 2018;55:561-6.
55. Snijders Blok L, Rousseau J, Twist J, Ehresmann S, Takaku M, et al. CHD3 helicase domain mutations cause a neurodevelopmental
syndrome with macrocephaly and impaired speech and language. Nat Commun 2018;9:4619.
56. Sifrim A, Hitz MP, Wilsdon A, Breckpot J, Al Turki SH, et al. Distinct genetic architectures for syndromic and nonsyndromic congenital
heart defects identified by exome sequencing. Nat Genet 2016;48:1060-5.
57. Carvill G, Helbig I, Mefford H. CHD2-related neurodevelopmental disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean
LJH, Stephens K, Amemiya A, editors. Seattle: University of Washington; 2015.
58. Martin DM. Epigenetic developmental disorders: CHARGE syndrome, a case study. Curr Genet Med Rep 2015;3:1-7.
59. Hartshorne TS, Hefner MA, Davenport SLH. Behavior in CHARGE syndrome: Introduction to the special topic. Am J Med Genet Part A
2005;133A:228-31.
60. Pagon RA, Graham JMJ, Zonana J, Yong SL. Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE
association. J Pediatr 1981;99:223-7.
61. Hota SK, Bruneau BG. ATP-dependent chromatin remodeling during mammalian development. Development 2016;143:2882-97.
62. Damaschke NA, Yang B, Blute ML, Lin CP, Huang W, et al. Frequent disruption of chromodomain helicase DNA-binding protein 8